Science ❯ Biology

Cancer Research

Immunology Tumor Biology Cell Structure Tumor Microenvironment Veterinary Oncology Solid Tumors Cancer Mechanisms Tumor Immunology Tumor Development Tumor Genetics Drug Development Glioblastoma Targeted Therapies Genome Stability Chromosomal Abnormalities Cancer Antigens Targeted Therapy Research Ethics Myeloid Cancers Microscopy

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

The purchase brings a first-in-class MLLT1/3 protein degrader into Amgen’s oncology research.

Dana-Farber to Pay $15 Million to Resolve DOJ Claims Over Manipulated Data in NIH-Funded Studies

Tunable Algae-Based Basement Membrane Replicates and Extends Matrigel for Breast Cell Studies

David Baltimore, Nobel Laureate Who Discovered Reverse Transcriptase, Dies at 87

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

UZH Researchers Unveil Real-Time CRISPR Platform to Decode Cancer Cell Evolution